HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Allan L Abramson Selected Research

Recurrent respiratory papillomatosis

4/2012Immune suppression in premalignant respiratory papillomas: enriched functional CD4+Foxp3+ regulatory T cells and PD-1/PD-L1/L2 expression.
1/2012T(H)2-like chemokine patterns correlate with disease severity in patients with recurrent respiratory papillomatosis.
6/2010Recurrent respiratory papillomatosis: a complex defect in immune responsiveness to human papillomavirus-6 and -11.
2/2010Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis.
9/2008Immune dysregulation and tumor-associated gene changes in recurrent respiratory papillomatosis: a paired microarray analysis.
7/2006Four mutations in Epidermodysplasia verruciformis 1 (EVER1) gene are not contributors to susceptibility in RRP.
3/2004Polymorphism of transporter associated with antigen presentation 1 as a potential determinant for severity of disease in recurrent respiratory papillomatosis caused by human papillomavirus types 6 and 11.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Allan L Abramson Research Topics

Disease

9Papilloma (Papillomatosis)
04/2012 - 03/2004
5Infection
01/2012 - 05/2004
4Neoplasms (Cancer)
01/2012 - 09/2005
3Rare Diseases (Rare Disease)
06/2010 - 03/2004
1Epidermodysplasia Verruciformis
07/2006
1Laryngeal Diseases
02/2005
1Tracheal Diseases
02/2005
1Dysphonia (Spastic Dysphonia)
09/2003

Drug/Important Bio-Agent (IBA)

7Recurrent respiratory papillomatosisIBA
04/2012 - 03/2004
3Messenger RNA (mRNA)IBA
04/2012 - 05/2004
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2012 - 09/2005
2celecoxib (Celebrex)FDA Link
01/2012 - 09/2005
2Epidermal Growth Factor Receptor (EGF Receptor)IBA
11/2010 - 09/2005
1harpin (messenger)IBA
01/2012
1NF-kappa B (NF-kB)IBA
11/2010
1Small Interfering RNA (siRNA)IBA
11/2010
1p21-Activated KinasesIBA
11/2010
1GTP Phosphohydrolases (GTPases)IBA
11/2010
1NF-kappaB inhibitor alphaIBA
11/2010
1KIR ReceptorsIBA
02/2010
1RNA (Ribonucleic Acid)IBA
09/2008
1Dinoprostone (PGE2)FDA Link
09/2005
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
09/2005
1Epidermal Growth Factor (EGF)IBA
09/2005
1Phosphotransferases (Kinase)IBA
09/2005
11-phenyl-3,3-dimethyltriazene (PDT)IBA
02/2005
1temoporfinIBA
02/2005
1Interleukin-18 (Interleukin 18)IBA
05/2004
1Interleukin-2 (IL2)IBA
05/2004
1DNA (Deoxyribonucleic Acid)IBA
03/2004

Therapy/Procedure

1Endoscopes
09/2003